Projects per year
Abstract
Context: Male ageing is associated with lower circulating testosterone (T) and increased incidence of cardiovascular disease (CVD). Whether physical activity (PA) interacts with hormones to modify CVD risk is unclear. Objective: We assessed whether PA and sex hormone concentrations were independently associated with measures of CVD risk. Participants: A total of 1649 men. Methods: Leisure, home, work and total PA were ascertained. At baseline, serum T, dihydrotestosterone (DHT) and oestradiol (E2) were assayed. Men were stratified into high PA+high hormone (H/H); low PA+high hormone (L/H); high PA+low hormone (H/L); and low PA+low hormone (L/L). Results: Mean age was 49.8 years at outset with 415 CVD events and 127 CVD deaths occurring during 20-year follow-up. Men with higher PA and higher T or DHT had lower odds of metabolic syndrome (eg leisure H/H vs L/L odds ratio [OR] 0.17 P<.001 for T, 0.26 P<.001 for DHT). Men with higher PA and E2 had lower risk of metabolic syndrome (eg leisure PA H/H vs L/L OR 0.51, P=.001). Men with higher leisure, work or total PA and higher DHT had the lowest risk of CVD death (eg leisure H/H hazard ratio [HR] 0.55 vs L/L, P=.033). Men with lower leisure, home or work PA and higher E2 were at greater risk of CVD death (eg leisure L/H HR 1.60 vs L/L, P=.039). Conclusions: Considering T, DHT and E2 in the context of PA better informs consideration of cardiovascular risk. A 2×2 factorial RCT assessing PA and androgens would illuminate the scope for preventing CVD in men.
Original language | English |
---|---|
Pages (from-to) | 466-474 |
Number of pages | 9 |
Journal | Clinical Endocrinology |
Volume | 87 |
Issue number | 5 |
DOIs | |
Publication status | Published - Nov 2017 |
Fingerprint
Dive into the research topics of 'Greater physical activity and higher androgen concentrations are independently associated with lower cardiometabolic risk in men'. Together they form a unique fingerprint.Projects
- 2 Finished
-
Personalised Exercise as Medicine - Optimising the Prescription to Maximise the Benefit
Green, D. (Investigator 01)
NHMRC National Health and Medical Research Council
1/01/15 → 31/12/20
Project: Research
-
Estradiol Testosterone & Cardiovascular Disease
Yeap, B. (Investigator 01), Hung, J. (Investigator 02), Knuiman, M. (Investigator 03), Beilby, J. (Investigator 04) & McQuillan, B. (Investigator 05)
NHMRC National Health and Medical Research Council
1/01/12 → 31/12/13
Project: Research